Wolverine Trading’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.08M | Buy |
43,900
+3,000
| +7% | +$406K | ﹤0.01% | 1242 |
|
|
2025
Q2 | $5.16M | Buy |
40,900
+3,600
| +10% | +$449K | 0.01% | 1039 |
|
|
2025
Q1 | $5.16M | Sell |
37,300
-18,800
| -34% | -$2.69M | 0.01% | 979 |
|
|
2024
Q4 | $8.43M | Buy |
56,100
+27,700
| +98% | +$4.67M | 0.01% | 876 |
|
|
2024
Q3 | $5.53M | Sell |
28,400
-2,100
| -7% | -$439K | 0.01% | 975 |
|
|
2024
Q2 | $7.07M | Buy |
30,500
+6,900
| +29% | +$1.5M | 0.01% | 792 |
|
|
2024
Q1 | $5.09M | Sell |
23,600
-6,700
| -22% | -$1.57M | 0.01% | 1010 |
|
|
2023
Q4 | $7.84M | Sell |
30,300
-3,500
| -10% | -$860K | 0.01% | 838 |
|
|
2023
Q3 | $8.69M | Buy |
33,800
+10,600
| +46% | +$2.84M | 0.01% | 687 |
|
|
2023
Q2 | $6.55M | Hold |
23,200
| – | – | 0.01% | 772 |
|
|
2023
Q1 | $6.38M | Sell |
23,200
-37,000
| -61% | -$10.2M | 0.01% | 717 |
|
|
2022
Q4 | $16.7M | Sell |
60,200
-40,000
| -40% | -$11.3M | 0.03% | 449 |
|
|
2022
Q3 | $26.5M | Buy |
100,200
+39,600
| +65% | +$8.41M | 0.04% | 245 |
|
|
2022
Q2 | $12.4M | Buy |
60,600
+17,000
| +39% | +$3.48M | 0.02% | 445 |
|
|
2022
Q1 | $9.2M | Sell |
43,600
-44,200
| -50% | -$9.61M | 0.01% | 736 |
|
|
2021
Q4 | $21.1M | Buy |
87,800
+9,000
| +11% | +$2.31M | 0.02% | 450 |
|
|
2021
Q3 | $22.5M | Sell |
78,800
-38,900
| -33% | -$12.7M | 0.03% | 481 |
|
|
2021
Q2 | $40.7M | Buy |
117,700
+35,500
| +43% | +$10.8M | 0.06% | 223 |
|
|
2021
Q1 | $22.7M | Sell |
82,200
-21,000
| -20% | -$5.66M | 0.03% | 357 |
|
|
2020
Q4 | $25.1M | Buy |
103,200
+17,200
| +20% | +$4.44M | 0.04% | 334 |
|
|
2020
Q3 | $24.3M | Buy |
86,000
+5,900
| +7% | +$1.65M | 0.06% | 247 |
|
|
2020
Q2 | $20.9M | Sell |
80,100
-7,200
| -8% | -$2.16M | 0.06% | 238 |
|
|
2020
Q1 | $27.6M | Sell |
87,300
-79,600
| -48% | -$24.2M | 0.08% | 159 |
|
|
2019
Q4 | $49.4M | Buy |
166,900
+100
| +0.1% | +$27.7K | 0.12% | 110 |
|
|
2019
Q3 | $38.4M | Buy |
166,800
+13,400
| +9% | +$3.12M | 0.11% | 136 |
|
|
2019
Q2 | $35.9M | Sell |
153,400
-40,900
| -21% | -$9.44M | 0.1% | 139 |
|
|
2019
Q1 | $45.9M | Buy |
194,300
+56,600
| +41% | +$17.8M | 0.13% | 101 |
|
|
2018
Q4 | $40.4M | Sell |
137,700
-16,100
| -10% | -$5.14M | 0.11% | 115 |
|
|
2018
Q3 | $54.3M | Buy |
153,800
+36,400
| +31% | +$12.5M | 0.12% | 91 |
|
|
2018
Q2 | $32.1M | Hold |
117,400
| – | – | 0.08% | 154 |
|
|
2018
Q1 | $32.1M | Sell |
117,400
-20,300
| -15% | -$6.3M | 0.08% | 154 |
|
|
2017
Q4 | $43.9M | Buy |
137,700
+51,100
| +59% | +$16.4M | 0.16% | 95 |
|
|
2017
Q3 | $27.1M | Sell |
86,600
-14,400
| -14% | -$4.26M | 0.1% | 164 |
|
|
2017
Q2 | $27.5M | Buy |
+101,000
| New | +$26.7M | 0.13% | 145 |
|
|
2017
Q1 | – | Sell |
-125,100
| Closed | -$35.5M | – | 4256 |
|
|
2016
Q4 | $35.5M | Buy |
+125,100
| New | +$37.1M | 0.17% | 103 |
|
|
2016
Q3 | – | Sell |
-108,800
| Closed | -$26M | – | 4594 |
|
|
2016
Q2 | $26M | Buy |
+108,800
| New | +$28.7M | 0.15% | 128 |
|
Other funds holding BIIB
Wolverine Trading's BIIB Position: Q3 2025 in Review
Wolverine Trading sold out of Biogen (BIIB) in Q3 2025, closing a stake of 6,667 shares — an estimated $901K sold.
Wolverine Trading first reported a position in BIIB in Q2 2016 and held it in 33 quarters. The position peaked at $11.7M in Q3 2019. 905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.
- Wolverine Trading reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
- Wolverine Trading sold 6,667 Biogen shares in Q3 2025, an estimated $901K.
- Wolverine Trading first reported a position in Biogen in Q2 2016 and held it in 33 quarters.
- Wolverine Trading's Biogen position peaked at $11.7M in Q3 2019.
- 905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.